Prostate cancer progression and surrounding microenvironment

被引:21
作者
Alberti, C. [1 ]
机构
[1] Univ Parma, I-43100 Parma, Italy
关键词
prostate; prostate cancer; disease progression; stromal-epithelial interaction;
D O I
10.1177/172460080602100204
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Bidirectional cellular interactions between prostate cancer and prostate or bone stroma are needed for local tumor growth and distant metastasis. The genetics of cancer cells is affected by the host microenvironment and, reciprocally, permanent gene expression changes occur in the stroma surrounding epithelial cancer cells. The immune-mediated micromilieu also affects the progression of prostate cancer; the role of the immune system in controlling the growth of prostate cancer cells is complex, with immune escape mechanisms prevailing over effective antitumor response. Moreover, tumor stem cell models to explain the origin and progression of prostate cancer require appropriate environmental conditions. On the basis of a review of the literature, this article aims to outline the recent advances in the elucidation of the molecular mechanisms underlying the interactions between prostate cancer and its microenvironment.
引用
收藏
页码:88 / 95
页数:8
相关论文
共 105 条
[1]   Inhibition of dendropoiesis by tumor derived and purified prostate specific antigen [J].
Aalamian, M ;
Tourkova, IL ;
Chatta, GS ;
Lilja, H ;
Huland, E ;
Huland, H ;
Shurin, GV ;
Shurin, MR .
JOURNAL OF UROLOGY, 2003, 170 (05) :2026-2030
[2]   Possible mechanism of dexamethasone therapy for prostate cancer: Suppression of circulating level of interleukin-6 [J].
Akakura, K ;
Suzuki, H ;
Ueda, T ;
Komiya, A ;
Ichikawa, T ;
Igarashi, T ;
Ito, H .
PROSTATE, 2003, 56 (02) :106-109
[3]   Bi-directional interactions of prostate cancer cells and bone marrow endothelial cells in three-dimensional culture [J].
Barrett, JM ;
Mangold, KA ;
Jilling, T ;
Kaul, KL .
PROSTATE, 2005, 64 (01) :75-82
[4]   Epothilones and the next generation of phase III trials for prostate cancer [J].
Bhandari, MS ;
Hussain, M .
BJU INTERNATIONAL, 2005, 96 (03) :296-302
[5]   Tumor-stroma interactions [J].
Bhowmick, NA ;
Moses, HL .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2005, 15 (01) :97-101
[6]  
Bistolfi F, 1991, BIOSTRUCTURES RAD OR, P53
[7]   LOSS OF HLA CLASS-I EXPRESSION IN PROSTATE-CANCER - IMPLICATIONS FOR IMMUNOTHERAPY [J].
BLADES, RA ;
KEATING, PJ ;
MCWILLIAM, LJ ;
GEORGE, NJR ;
STERN, PL .
UROLOGY, 1995, 46 (05) :681-686
[8]   Activation of osteocalcin transcription involves interaction of protein kinase A- and protein kinase C-dependent pathways [J].
Boguslawski, G ;
Hale, LV ;
Yu, XP ;
Miles, RR ;
Onyia, JE ;
Santerre, RF ;
Chandrasekhar, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (02) :999-1006
[9]   Osteoprotegerin and rank ligand expression in prostate cancer [J].
Brown, JM ;
Corey, E ;
Lee, ZD ;
True, LD ;
Yun, TJ ;
Tondravi, M ;
Vessella, RL .
UROLOGY, 2001, 57 (04) :611-616
[10]   SIGNALING, MITOGENESIS AND THE CYTOSKELETON - WHERE THE ACTION IS [J].
CARRAWAY, KL ;
CARRAWAY, CAC .
BIOESSAYS, 1995, 17 (02) :171-175